Risks of SARS-CoV-2 JN.1 infection and COVID-19 associated emergency-department (ED) visits/hospitalizations following updated boosters and prior infection: a population-based cohort study.

Cheryl ChongLiang En Ian WeeXuan JinMengyang ZhangMuhammad Ismail Abdul MalekBenjamin OngDavid LyeCalvin J ChiewKelvin Bryan Tan

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)

Recent receipt of updated boosters conferred protection against SARS-CoV-2 infection and ED-visits/hospitalization during a JN.1 variant wave, in both previously infected and uninfected individuals. Annual booster doses confer protection during COVID-19 endemicity.

Keyphrases

emergency department
sars cov
respiratory syndrome coronavirus
coronavirus disease
hiv infected
human health
adverse drug
climate change
electronic health record
drug induced